Related Experiment Video
Updated: Jan 14, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Mapping the BCSC-1 interactome in breast cancer
Yuan Ma1,2, Qingchen Zhang1, Jiyu Ju1
1Key Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province, Shandong Second Medical University, Weifang, 261053, Shandong Province, China.
Abstract:
BCSC-1 (breast cancer suppressor candidate-1), the official gene symbol VWA5A (von Willebrand factor A domain containing 5 A), is downregulated in a variety of cancer types including breast cancer. The role of BCSC-1 in tumorigenesis and the underlying mechanisms are poorly understood. One of the ways to predict a spectrum of functions of an unknown protein is to identify the protein-protein interaction network involving it. Flag-pLV-Neo-BCSC1 or the empty vector were stably transfected into breast cancer cells MCF-7. The levels of BCSC1 expression were identified by Western blotting. Co-immunoprecipitation assay coupled with liquid chromatography with tandem mass spectrometry (Co-IP-MS) and bioinformatic analysis were done to study protein-protein interactions. A subset of interacting proteins was validated by immunofluorescence (IF). IF was also conducted to determine the cell migration of BCSC-1. The pEGFP-C3 plasmids with full-length and truncated BCSC-1 were transiently transfected into breast cancer cells to identify domains of BCSC-1 guiding the subcellular location. 341 interacting partners of BCSC-1 were significantly enriched in Flag-BCSC-1 against negative control. These interactors included the lysosome and the proteasome related to proteostatic pathways, the peroxisome involved in lipid metabolism, endocytosis components in the vesicle transport pathway, and the regulation of actin cytoskeleton. STAT1, STAT3, and CDC42, identified among the interacting partners, co-localized with BCSC-1. In addition, BCSC-1 distributed to the leading edge of migrating breast cancer cells. VIT (vault protein inter-α-trypsin) domain of BCSC-1 is required in the regulation of cell migration. BCSC-1 might exert diverse functions through protein-protein interactions.
Insights
Breast cancer suppressor candidate-1 (BCSC-1) interacts with 341 proteins, influencing cell migration and proteostasis. Its VIT domain is crucial for regulating breast cancer cell movement.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Breast cancer suppressor candidate-1 (BCSC-1), also known as VWA5A, is downregulated in various cancers, including breast cancer.
- The precise functions and mechanisms of BCSC-1 in tumorigenesis remain largely unknown.
- Understanding protein-protein interactions is key to elucidating novel protein functions.
Purpose of the Study:
- To identify the protein-protein interaction network of BCSC-1.
- To investigate the role of BCSC-1 in breast cancer cell migration.
- To determine the domains of BCSC-1 involved in its cellular functions.
Main Methods:
- Stable transfection of breast cancer cells (MCF-7) with BCSC-1.
- Co-immunoprecipitation coupled with mass spectrometry (Co-IP-MS) to identify interacting proteins.
- Bioinformatic analysis, Western blotting, immunofluorescence (IF), and plasmid transfections to validate interactions and study cell migration.
Main Results:
- 341 significant interacting partners of BCSC-1 were identified.
- Interacting proteins are involved in proteostasis (lysosome, proteasome), lipid metabolism (peroxisome), vesicle transport, and actin cytoskeleton regulation.
- BCSC-1 co-localizes with STAT1, STAT3, and CDC42, and is found at the leading edge of migrating cells.
- The VIT domain of BCSC-1 is essential for regulating cell migration.
Conclusions:
- BCSC-1 interacts with a diverse set of proteins, suggesting multifaceted roles in cellular processes.
- BCSC-1 plays a role in regulating breast cancer cell migration, potentially through its VIT domain.
- The identified interactors provide insights into the molecular mechanisms underlying BCSC-1's function in cancer.

